Avai Bio (AVAI) Notes Payables (2018 - 2025)
Avai Bio's Notes Payables history spans 7 years, with the latest figure at $99000.0 for Q1 2024.
- On a quarterly basis, Notes Payables changed 0.0% to $99000.0 in Q1 2024 year-over-year; TTM through Mar 2024 was $99000.0, a 0.0% change, with the full-year FY2024 number at $99000.0, changed 0.0% from a year prior.
- Notes Payables hit $99000.0 in Q1 2024 for Avai Bio, down from $295500.0 in the prior quarter.
- Over the last five years, Notes Payables for AVAI hit a ceiling of $295500.0 in Q4 2023 and a floor of $35424.0 in Q2 2020.
- Historically, Notes Payables has averaged $150537.4 across 5 years, with a median of $149000.0 in 2020.
- Biggest five-year swings in Notes Payables: soared 14721.76% in 2020 and later plummeted 41.59% in 2023.
- Tracing AVAI's Notes Payables over 5 years: stood at $149000.0 in 2020, then changed by 0.0% to $149000.0 in 2021, then increased by 13.76% to $169500.0 in 2022, then surged by 74.34% to $295500.0 in 2023, then plummeted by 66.5% to $99000.0 in 2024.
- Business Quant data shows Notes Payables for AVAI at $99000.0 in Q1 2024, $295500.0 in Q4 2023, and $169500.0 in Q3 2023.